Birmingham biotech company receives $1.2M toward research
June 15, 2022 at 23:14 PM EDT
A Birmingham biotech company has received over a million dollars in funding toward research to treat a chronic kidney disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|